Nextage Therapeutics Ltd (NXTG.TA)

ILA 104.5

(0.97%)

Net Debt Summary of Nextage Therapeutics Ltd

Nextage Therapeutics Ltd's latest annual net debt in 2023 was -26 Thousand ILS , up 96.37% from previous year.
Nextage Therapeutics Ltd's latest quarterly net debt in 2023 FY was -26 Thousand ILS , up 96.37% from previous quarter.
Nextage Therapeutics Ltd reported annual net debt of -717 Thousand ILS in 2022, up 62.58% from previous year.
Nextage Therapeutics Ltd reported annual net debt of -1.91 Million ILS in 2021, down -60.6% from previous year.
Nextage Therapeutics Ltd reported quarterly net debt of -26 Thousand ILS for 2023 FY, up 96.37% from previous quarter.
Nextage Therapeutics Ltd reported quarterly net debt of 555 Thousand ILS for 2023 Q2, up 177.41% from previous quarter.

Annual Net Debt Chart of Nextage Therapeutics Ltd (2023 - 2017)

Historical Annual Net Debt of Nextage Therapeutics Ltd (2023 - 2017)

Year	Net Debt	Net Debt Growth
2023	-26 Thousand ILS	96.37%
2022	-717 Thousand ILS	62.58%
2021	-1.91 Million ILS	-60.6%
2020	-1.19 Million ILS	-10.46%
2019	-1.08 Million ILS	-280.6%
2018	598 Thousand ILS	150.55%
2017	-1.18 Million ILS	0.0%

Year	Net Debt	Net Debt Growth
2023 Q4	-26 Thousand ILS	-104.68%
2023 FY	-26 Thousand ILS	96.37%
2023 Q2	555 Thousand ILS	177.41%
2022 Q4	-717 Thousand ILS	77.22%
2022 FY	-717 Thousand ILS	62.58%
2022 Q2	-3.14 Million ILS	-64.25%
2021 Q4	-1.91 Million ILS	45.19%
2021 Q2	-3.49 Million ILS	-193.04%
2021 FY	-1.91 Million ILS	-60.6%
2020 Q2	-323 Thousand ILS	70.09%
2020 FY	-1.19 Million ILS	-10.46%
2020 Q4	-1.19 Million ILS	-269.35%
2019 FY	-1.08 Million ILS	-280.6%
2019 Q4	-1.08 Million ILS	-1127.27%
2019 Q2	-88 Thousand ILS	-114.72%
2018 FY	598 Thousand ILS	150.55%
2018 Q4	598 Thousand ILS	0.0%
2017 FY	-1.18 Million ILS	0.0%

Peer Net Debt Comparison of Nextage Therapeutics Ltd

Name	Net Debt	Net Debt Difference
Cannabotech LTD	1.05 Million ILA	102.46%